Revisiting the stress concept: implications for affective disorders
BS McEwen, H Akil - Journal of Neuroscience, 2020 - Soc Neuroscience
Over the last 50 years, the concept of stress has evolved significantly, and our
understanding of the underlying neurobiology has expanded dramatically. Rather than …
understanding of the underlying neurobiology has expanded dramatically. Rather than …
[HTML][HTML] Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
B Lüscher, H Möhler - F1000Research, 2019 - ncbi.nlm.nih.gov
The GABAergic deficit hypothesis of depression states that a deficit of GABAergic
transmission in defined neural circuits is causal for depression. Conversely, an …
transmission in defined neural circuits is causal for depression. Conversely, an …
Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice
S Yao, MD Xu, Y Wang, ST Zhao, J Wang… - Nature …, 2023 - nature.com
Alterations in energy metabolism are associated with depression. However, the role of
glycolysis in the pathogenesis of depression and the underlying molecular mechanisms …
glycolysis in the pathogenesis of depression and the underlying molecular mechanisms …
Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice
R Rawat, E Tunc-Ozcan, TL McGuire, CY Peng… - Nature …, 2022 - nature.com
Ketamine treatment decreases depressive symptoms within hours, but the mechanisms
mediating these rapid antidepressant effects are unclear. Here, we demonstrate that activity …
mediating these rapid antidepressant effects are unclear. Here, we demonstrate that activity …
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
M Kokkinou, EE Irvine, DR Bonsall, S Natesan… - Molecular …, 2021 - nature.com
Patients with schizophrenia show increased striatal dopamine synthesis capacity in imaging
studies. The mechanism underlying this is unclear but may be due to N-methyl-D-aspartate …
studies. The mechanism underlying this is unclear but may be due to N-methyl-D-aspartate …
Therapeutic mechanisms of psychedelics and entactogens
BD Heifets, DE Olson - Neuropsychopharmacology, 2024 - nature.com
Recent clinical and preclinical evidence suggests that psychedelics and entactogens may
produce both rapid and sustained therapeutic effects across several indications. Currently …
produce both rapid and sustained therapeutic effects across several indications. Currently …
Transcriptional signatures of early-life stress and antidepressant treatment efficacy
ST Parel, SN Bennett, CJ Cheng… - Proceedings of the …, 2023 - National Acad Sciences
Individuals with a history of early-life stress (ELS) tend to have an altered course of
depression and lower treatment response rates. Research suggests that ELS alters brain …
depression and lower treatment response rates. Research suggests that ELS alters brain …
BDNF as a mediator of antidepressant response: recent advances and lifestyle interactions
S Cubillos, O Engmann, A Brancato - International journal of molecular …, 2022 - mdpi.com
Conventional antidepressants are widely employed in several psychiatric and neurologic
disorders, yet the mechanisms underlying their delayed and partial therapeutic effects are …
disorders, yet the mechanisms underlying their delayed and partial therapeutic effects are …
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine
BK Chen, VM Luna, CT LaGamma, X Xu… - …, 2020 - nature.com
Enhancing stress resilience in at-risk populations could significantly reduce the incidence of
stress-related psychiatric disorders. We have previously reported that the administration of …
stress-related psychiatric disorders. We have previously reported that the administration of …
Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites
While the molecular target of (R, S)-ketamine (ketamine) is thought to be the NMDA receptor,
subanesthetic doses of ketamine have been known to modulate monoaminergic …
subanesthetic doses of ketamine have been known to modulate monoaminergic …